Darunavir and Cobicistat
- Generic Name
- Darunavir and Cobicistat
Overview
No overview information available.
Background
No background information available.
Indication
用于与其他抗逆转录病毒药物联合使用治疗人类免疫缺陷病毒（HIV）感染成年患者，其中包括：抗逆转录病毒药物初治成年患者，以及未出现达芦那韦耐药相关突变的既往接受抗逆转录病毒药物治疗的成年患者。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2018/12/20 | N/A | Completed |
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
Singapore Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. | Online |
|---|
No Singapore products found
No Singapore products found for this drug
China Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
Darunavir and Cobicistat Tablets | 国药准字HJ20180030 | Janssen Ortho, Llc | 片剂 | 普泽力 | 每片含800mg达芦那韦(相当于867.28mg达芦那韦乙醇合物)和150mg考比司他 | Chemical Drug | Approved | 2023/06/14 | Import |
Australia Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|
No Australia products found
No Australia products found for this drug
© Copyright 2025. All Rights Reserved by MedPath